Different profiles of allelic losses in cervical carcinoma cases in Surinam and the Netherlands

Cancer

Volumn 86, Issue 6, 1999, Pages 997-1004

  Krul, Eveline J T ^a   Kersemaekers, Anne Marie F ^a   Zomerdijk Nooyen, Yvon A ^a   Cornelisse, Cees J ^a   Peters, Lex A W ^a   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical neoplasms; Chromosomes; Comparative study; Ethnic groups; Heterogeneity; Loss of heterozygosity; Surinam; The Netherlands

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER RISK; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 6Q; COMPARATIVE STUDY; ETHNIC GROUP; FEMALE; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NETHERLANDS; POPULATION RISK; PRIORITY JOURNAL; SURINAME; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; CARCINOMA; DNA, VIRAL; FEMALE; GENETIC HETEROGENEITY; HUMANS; INCIDENCE; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; NETHERLANDS; PAPILLOMAVIRIDAE; SURINAME; UTERINE CERVICAL NEOPLASMS;

EID: 0033567950     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990915)86:6<997::AID-CNCR15>3.0.CO;2-Q     Document Type: Article

References (33)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1985;54:594-606.
2. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Vol. VII. Series 143. Lyon: IARC Scientific Publications, 1997.
3. Kjaer SK, Jensen OM. Comparison studies of HPV detection in areas at different risk for cervical cancer. In: Muñoz N, Bosch FX, Shah KV, Meheus A, editors. The epidemiology of human papillomavirus and cervical cancer. Lyon: International Agency for Research on Cancer, 1992:243-9.
4. Remmink AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61:306-11.
5. Zur Hausen H, Rösl F. Pathogenesis of cancer of the cervix. Cold Spring Harbor Symp Quant Biol 1994;59:623-8.
6. Zur Hausen H, de Villiers EM. Human papillomaviruses. Annu Rev Microbiol 1994;48:427-47.
7. Zur Hausen H. Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix? Int J Cancer 1995;63:315-6.
8. Mitra AB, Murty VVVS, Li RG, Pratap M, Luthra UK, Chaganti RSK. Allelotype analysis of cervical carcinoma. Cancer Res 1994;54:4481-7.
9. Rader JS, Kamarasova T, Huettner PC, Li L, Li Y, Gerhard DS. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene 1996;13:2737-41.
10. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res 1996;56:197-205.
11. Kersemaekers AMF, Hermans J, Fleuren GJ, Vijver van de MJ. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer 1997;77:192-200.
12. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87: 796-802.
13. Chaouki N, Bosch FX, Muñoz N, Meijer CJ, El Gueddari B, El Ghazi A, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-54.
14. Huang S, Afonina I, Miller BA, Beckmann AM. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 1997;70:408-11.
15. Chichareon S, Herrero R, Muñoz N, Bosch FX, Jacobs MV, Deacon J, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-7.
16. Paterson IC, Eveson JW, Prime SS. Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral Oncol 1996;32B:150-3.
17. Wang L, Li W, Wang X, Zhang C, Zhang T, Mao X, et al. Genetic alterations on chromosomes 3 and 9 of esophageal cancer tissues from China. Oncogene 1996;12:699-703.
18. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res 1994;54:281-5.
19. Weinstein IB, Santella RM, Perera F. Molecular biology and epidemiology of cancer. In: Greenwald P, Kramer BS, Weed DL, editors. Cancer prevention and control. New York: Marcel Dekker, 1995:83-110.
20. Krul EJT, Peters AAW, Vandenbroucke JP, Vrede MA, van Kanten RW, Fleuren GJ. Cervical carcinoma in Surinam: incidence and staging of cervical cancer between 1989 through 1994. Cancer 1996;77:1329-33.
21. FIGO-Federation Internationale de Gynecology et Obsterique. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
22. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989;44:388-96.
23. Devilee P, van Schothorst EM, Bardoel AF, Bonsing B, Kuipers Dijkshoorn N, James MR, et al. Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL. Genes Chromosomes Cancer 1994;11:71-8.
24. Tieben LM, Ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ, et al. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 1993;42:265-79.
25. Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M., editors. Molecular diagnostics of human cancer, cancer cells. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989:209-14.
26. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
27. Bauer HM, Greer CE, Manos MM. Determination of genital human papillomavirus infection by consensus PCR amplification. In: Herrington CS, McGee JO, editors. Diagnostic molecular pathology. A practical approach. Oxford: Oxford University Press, 1992:131-52.
28. Kisseljov F, Semionova L, Samoylova E, Mazurenko N, Komissarova E, Zourbitskaya V, et al. Instability of chromosome 6 microsatellite repeats in human cervical tumors carrying papillomavirus sequences. Int J Cancer 1996;69: 484-7.
29. Biggs JR, Kraft AS. Inhibitors of cyclin-dependent kinase and cancer. J Mol Med 1995;73:509-14.
30. Guo Z, Wilander E, Sallstrom J, Ponten J. Deletion of chromosome 3p is an early event in malignant progression of cervical cancer. Anticancer Res 1998;18:707-12.
31. Vessey CJ, Wilding J, Folarin N, Hirano S, Takeichi M, Soutter P, et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma J Pathol 1995;176:151-9.
32. Weinstein IB. Synergistic interactions between chemical carcinogens, tumor promoters, and viruses and their relevance to human liver cancer. Cancer Detect Prev 1989;14: 253-9.
33. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-6.